Syros Pharmaceuticals (SYRS) PT Lowered to $24 at Piper Jaffray
Tweet Send to a Friend
Piper Jaffray analyst Edward Tenthoff lowered the price target on Syros Pharmaceuticals (NASDAQ: SYRS) to $24.00 (from $28.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
